{
  "id": "CD008550.PUB3",
  "draft": "What are the effects of medicines in treating gastro-oesophageal reflux (a condition where stomach acid flows back into the throat) in children?\n\nKey Messages\n- We don't know for sure how well medicines work for children with gastro-oesophageal reflux.\n- There is not enough good evidence to know if specific drugs—like omeprazole, esomeprazole, or other proton pump inhibitors (medicines that reduce stomach acid)—are helpful.\n- For children with more severe reflux (called GORD), it's also unclear if these medicines help. GORD is when reflux causes symptoms bad enough to need treatment. More research is needed to know for sure.\n\nWhat is gastro-oesophageal reflux in children?\nGastro-oesophageal reflux (GOR) happens when what's in the stomach comes back up into the food pipe (oesophagus). This can cause symptoms like spitting up (regurgitation). It's a common problem in infants, affecting about 50% of those under three months old, and can also occur in older children. While GOR often improves with age, some children may experience symptoms that last longer, especially if they have other health problems.\n\nWhy is gastro-oesophageal reflux a problem?\nGOR can be a self-limiting condition, but for some children, it can lead to more severe symptoms and complications. It's essential to distinguish between GOR and gastro-oesophageal reflux disease (GORD). GORD is when reflux causes symptoms severe enough to need treatment. Guidelines from the National Institute of Health and Care Excellence (NICE) say it is crucial to treat GORD.\n\nWhat are the common treatments for gastro-oesophageal reflux in children?\nMedicines, such as proton pump inhibitors (PPIs), are often used to manage GOR in children. However, the effectiveness of these treatments can vary, and there is a need to assess their benefits and potential harms.\n\nWhat did we want to find out?\nWe wanted to find out how well different medicines work for treating GOR in children, including their benefits and harms. We looked at which treatments are most effective in improving symptoms and reducing the risk of complications.\n\nHow did we do the review?\nWe searched for studies that tested medicines for reflux in children, summarized their results, and rated our confidence in the evidence.\n\nWhat did we find?\nWe found 36 studies that involved 2251 children and infants with gastro-oesophageal reflux. The studies included infants up to 12 months old and children aged 12 months to 16 years old, with some focusing on specific age groups like neonates. Interventions included medicines such as omeprazole, esomeprazole, ranitidine, and proton pump inhibitors, compared to a placebo or other medications.\n\nUnfortunately, there wasn't enough data to assess other medications. More studies with longer follow-up are needed, especially for groups like preterm babies and children with neurodisabilities.\n\nOverall, the evidence was not strong enough to show if medicines help infants or older children with reflux. For specific drugs like omeprazole and other proton pump inhibitors, we could not find clear evidence that they improve symptoms.\n\nWhat are the limitations of the evidence?\nThe evidence is limited because the studies were small and did not look at all the different types of children, medicines, or results that are important to families.\n\nHow up-to-date is this evidence?\nThis review updates our previous review. The evidence is up to date to September 2022.\n\nFuture research should look at the long-term effects of these medicines. We need to understand their benefits and harms for different groups, like premature babies or children with disabilities. This will help families and doctors make better decisions.",
  "metrics": [
    {
      "linguistic_evaluation": {
        "words": {
          "value": 615,
          "rating": "within_limit",
          "direction": null,
          "feedback": null
        },
        "sentences": {
          "value": 37,
          "rating": "info",
          "direction": null,
          "feedback": null
        },
        "words_per_sentence": {
          "value": 16.62162162162162,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "passive_voice": {
          "value": 7,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "active_voice": {
          "value": 66,
          "rating": "P75",
          "direction": "higher_better",
          "feedback": null
        },
        "pronouns": {
          "value": 43,
          "rating": "P75",
          "direction": "higher_better",
          "feedback": null
        },
        "nominalization": {
          "value": 16,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "nouns": {
          "value": 165,
          "rating": "P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 165.0 to <116.0 (median)"
        },
        "flesch_reading_ease": {
          "value": 55.979663810151635,
          "rating": "P75",
          "direction": "higher_better",
          "feedback": null
        },
        "flesch_kincaid_grade": {
          "value": 9.580562513733245,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "automated_readability_index": {
          "value": 9.596030323005934,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "coleman_liau_index": {
          "value": 10.777040650406505,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "gunning_fog_index": {
          "value": 12.43726653482751,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "lix": {
          "value": 43.125686662272024,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "rix": {
          "value": 4.405405405405405,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "smog_index": {
          "value": 12.899494936611665,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "dale_chall_readability": {
          "value": 6.34451373324544,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "complex_words_dc": {
          "value": 215,
          "rating": "P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 215.0 to <160.0 (median)"
        },
        "complex_words": {
          "value": 89,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "long_words": {
          "value": 163,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        }
      },
      "word_count_status": {
        "word_count": 615,
        "limit": 850,
        "status": "within_limit",
        "message": "Word count: 615 ✓ WITHIN LIMIT (≤850 words)"
      },
      "summary": {
        "P25_count": 9,
        "P50_count": 0,
        "P75_count": 7,
        "P90_count": 2,
        "P10_count": 0,
        "BEYOND_P90_count": 0,
        "BELOW_P10_count": 0,
        "total_evaluated": 18,
        "P25_percentage": 50,
        "P50_percentage": 0,
        "P75_percentage": 38.88888888888889,
        "P90_percentage": 11.11111111111111,
        "P10_percentage": 0,
        "BEYOND_P90_percentage": 0,
        "BELOW_P10_percentage": 0,
        "best_quartile_rate": 88.88888888888889,
        "overall_assessment": "HIGHLY CONFORMS TO TYPICAL PLS PATTERNS"
      }
    }
  ],
  "evaluation": [
    {
      "grade": "NOT_APPROVED",
      "feedback": "This is a strong draft that is clear, accurate, and well-structured. All critical checks for completeness, formatting, and accuracy have passed. However, a few revisions are needed to improve clarity and flow for a patient audience before it can be approved. My top 3 recommendations focus on making the key messages more concise, simplifying technical references, and making the results more concrete.\n\n### Top 3 Improvements Needed\n\n**1. Combine Repetitive Key Messages**\n\n*   **The Issue:** The first two key messages say very similar things, which can weaken the main takeaway.\n*   **Original Text:**\n    > - We don't know for sure how well medicines work for children with gastro-oesophageal reflux.\n    > - There is not enough good evidence to know if specific drugs—like omeprazole, esomeprazole, or other proton pump inhibitors (medicines that reduce stomach acid)—are helpful.\n*   **Suggested Rewrite:** Combine them into a single, more powerful message.\n    > - We don't know for sure how well medicines work for children with reflux, as there is not enough good evidence to know if specific drugs like proton pump inhibitors (which reduce stomach acid) are helpful.\n\n**2. Clarify the Reference to NICE Guidelines**\n\n*   **The Issue:** The reference to NICE is abrupt and uses an acronym that may be unfamiliar to a global audience. This sentence is also noun-heavy, which can make it harder to read.\n*   **Original Text:**\n    > Guidelines from the National Institute of Health and Care Excellence (NICE) say it is crucial to treat GORD.\n*   **Suggested Rewrite:** Rephrase to be more active and provide context for the acronym.\n    > In the UK, health experts (called NICE) emphasize that it is important to treat GORD when symptoms are severe.\n\n**3. Make the Main Finding More Concrete**\n\n*   **The Issue:** The summary of the findings is a bit abstract. Adding a specific comparison would make the result easier for readers to grasp.\n*   **Original Text:**\n    > Overall, the evidence was not strong enough to show if medicines help infants or older children with reflux. For specific drugs like omeprazole and other proton pump inhibitors, we could not find clear evidence that they improve symptoms.\n*   **Suggested Rewrite:** Add an example to make the finding more tangible.\n    > Overall, we did not find strong enough evidence to show whether medicines help infants or older children with reflux. For example, there was no clear evidence that commonly used drugs like omeprazole improved symptoms any more than a placebo (a dummy treatment).",
      "pls_evaluation_summary": "The linguistic analysis shows the draft highly conforms to typical PLS patterns, with 89% of features falling in the best quartile for readability and plain language. However, the analysis identified two deviations that support the need for revision: the noun count (165) and the count of complex words from the Dale-Chall list (215) are both in the 90th percentile. This suggests that simplifying sentence structures and replacing some uncommon words would further improve clarity for readers."
    }
  ]
}